Literature DB >> 2928808

Idarubicin in acute leukemia: results of studies at Memorial Sloan-Kettering Cancer Center.

E Berman1, V Raymond, T Gee, S J Kempin, S Gulati, M Andreeff, J Kolitz, J Gabrilove, G Heller, C W Young.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2928808

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  4 in total

Review 1.  Idarubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer.

Authors:  L M Hollingshead; D Faulds
Journal:  Drugs       Date:  1991-10       Impact factor: 9.546

Review 2.  Idarubicin: a pharmacoeconomic evaluation of its use in adult patients with acute myeloid leukaemia.

Authors:  R Whittington; K L Goa
Journal:  Pharmacoeconomics       Date:  1993-10       Impact factor: 4.981

Review 3.  Acute myeloid leukemia in the elderly: biological features and search for adequate treatment.

Authors:  V Heinemann; U Jehn
Journal:  Ann Hematol       Date:  1991-10       Impact factor: 3.673

4.  Acute myeloblastic leukaemia--a model for assessing value for money for new treatment programmes.

Authors:  P J Lobo; R L Powles; A Hanrahan; D K Reynold
Journal:  BMJ       Date:  1991-02-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.